Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Nevro Q4 2023 GAAP EPS $(0.25) Beats $(0.49) Estimate, Sales $116.18M Beat $112.48M Estimate

Author: Benzinga Newsdesk | February 21, 2024 05:30pm
Nevro (NYSE:NVRO) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.49) by 48.98 percent. This is a 53.7 percent increase over losses of $(0.54) per share from the same period last year. The company reported quarterly sales of $116.18 million which beat the analyst consensus estimate of $112.48 million by 3.29 percent. This is a 2.05 percent increase over sales of $113.84 million the same period last year.

Posted In: NVRO